// App-Quantinova.ai

S2124 2015 AHA : Long-term Population-based Outcomes of Novel Oral Anticoagulants Compared to Warfarin Among Long-term Anticoagulated Patients: A Propensity Matched Analysis

Researchers

Presenter

  • Heidi T May

Principal Investigators

  • Tami L Bair

  • Scott C Woller

  • T Jared Bunch

  • Jeffrey L Anderson

  • Brian G Crandall

  • Michael Cutler

  • John D Day

  • Charles D Mallender II

  • Jeffrey S Osborn

  • Scott M Stevens

  • J Peter Weiss

Medical Centers

  • Intermountain Med Ctr, Murray, UT

  • Intermountain Medical Ctr, Univ of Utah, Murray, UT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

  • Warfarin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim